Pharmaceutical-Industry

5 of Last Week's Biggest Losers

There's never a shortage of stocks going the wrong way in any given chunk of time. No stock goes straight up, and sometimes fundamentals can...

5 Stocks to Watch This Week

There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come. MondayPeregrine...

3 Crashing Biotechs: Is 1 a Buy?

Healthcare has been on a run this year, but not all of the companies in the sector have gone higher. These three have all dropped by more...

Is This MannKind's Greatest Risk?

Not long ago, some predicted that MannKind faced the serious risk of striking out on winning approval for Afrezza. Instead, those...

Down 17%: Is Sarepta a Bad News Buy?

Duchenne muscular dystrophy, or DMD, drugmakers have been on a win streak lately, with Prosensa , Sarepta Therapeutics and PTC Therapeutics...

Drugmakers and Dublin

On Tuesday's Market Foolery, host Chris Hill and Bill Barker, a Motley Fool Funds analyst, jump into the murky waters of AbbVie's latest bid...

Why PetSmart Shares Are Rallying

PetSmart is a company with some undeniable tailwinds. The industry it operates in, pet care, is booming and is nearly recession-proof....